Max Healthcare: Strong Growth & Ambitious Expansion

Q4 FY25 Highlights: Gross Revenue: Increased by a significant 29% year-on-year to ₹2,429 crore. Profit After Tax (PAT): Grew by 21% year-on-year to ₹376 crore. (Some reports indicate a consolidated PAT of ₹319 crore with a 26.82% increase, but the company's gross revenue and PAT figures for the entire network are ₹2,429 crore and ₹376 crore, respectively, as per their investor presentation.) Operating EBITDA: Rose by 26% to ₹632 crore, with network operating margins at 27.2%. Bed Occupancy: Maintained a healthy 75%, with occupied bed days (OBDs) up 30% year-on-year. Average Revenue Per Occupied Bed (ARPOB): Stood at ₹77,100. This marks the 18th consecutive quarter of year-on-year growth in both Revenue and Operating EBITDA. Full Year FY25 Highlights: Gross Revenue: Reached ₹9,000 crore, a 26% increase from the previous fiscal year. (Some reports indicate consolidated revenue from operations at ₹7,028.46 crore, up 30.01% for FY25.) Net Profit: Grew to ₹1,392 crore (or ₹1,075.88 crore consolidated). Network Operating EBITDA: Grew by 22% over FY22-23 to ₹2,319 crore. Dividend: The board has recommended a final dividend of ₹1.5 per equity share for FY25, subject to shareholder approval. Future Outlook & Expansion: Max Healthcare plans to invest ₹6,000 crore by 2028 to add 3,700 beds, aiming for approximately 30 hospitals across India. They will operationalize three new brownfield towers in Saket, Nanavati, and Mohali hospitals within the next three months, adding 1,500 beds in the current financial year. The company is also pursuing opportunistic acquisitions.